Literature DB >> 12669268

Phenotypic gender differences in subjects with familial partial lipodystrophy (Dunnigan variety) due to a nuclear lamin A/C R482W mutation.

D Araújo-Vilar1, L Loidi, F Domínguez, J Cabezas-Cerrato.   

Abstract

Phenotypic features appeared after puberty in female, but not male subjects with familial partial lipodystrophy (FPLD). We have studied anthropometrical, clinical, and metabolic gender differences in a Spanish family with FPLD resulting from a lamin A/C gene mutation, R482W. Genetic studies were carried out on 14 members of the family. In eleven heterozygous mutation carriers (6 men, 5 women), body composition was evaluated by bioelectric impedance analysis, skin-fold measurements were taken, and lipid profiles were drawn. Moreover, plasma glucose, insulin, and leptin were determined, and insulin resistance and beta cell response were evaluated using HOMA. Ten healthy women and 10 healthy men matched for age and body mass index were used as control group. Body composition was similar in these patients to normal people. However, skin-folds of extremities were thinner in FPLD women compared with those of control subjects, but not in men. The affected women, but not men, showed hypoleptinaemia, insulin resistance, and beta-cell hyperresponse compared with unaffected women. The lipid profile was normal in the young patients, irrespective of sex. Type 2 diabetes mellitus and hypertriglyceridaemia were detected in old and overweight patients only. In conclusion, molecular diagnosis allows us to demonstrate that women with FPLD present both adipose tissue and biochemical abnormalities early in life, and this did not happen in affected men.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12669268     DOI: 10.1055/s-2003-38388

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  12 in total

Review 1.  What the genetics of lipodystrophy can teach us about insulin resistance and diabetes.

Authors:  Camille Vatier; Guillaume Bidault; Nolwenn Briand; Anne-Claire Guénantin; Laurence Teyssières; Olivier Lascols; Jacqueline Capeau; Corinne Vigouroux
Journal:  Curr Diab Rep       Date:  2013-12       Impact factor: 4.810

2.  Association of metreleptin treatment and dietary intervention with neurological outcomes in Celia's encephalopathy.

Authors:  David Araújo-Vilar; Rosario Domingo-Jiménez; Álvaro Ruibal; Pablo Aguiar; Salvador Ibáñez-Micó; Miguel Garrido-Pumar; Miguel Ángel Martínez-Olmos; Concepción López-Soler; Cristina Guillín-Amarelle; María González-Rodríguez; Antonio Rodríguez-Núñez; Julián Álvarez-Escudero; Mercedes Liñares-Paz; Blanca González-Méndez; Silvia Rodríguez-García; Sofía Sánchez-Iglesias
Journal:  Eur J Hum Genet       Date:  2018-01-24       Impact factor: 4.246

3.  Type 1 familial partial lipodystrophy: understanding the Köbberling syndrome.

Authors:  Cristina Guillín-Amarelle; Sofía Sánchez-Iglesias; Ana Castro-Pais; Leticia Rodriguez-Cañete; Lucía Ordóñez-Mayán; Marcos Pazos; Blanca González-Méndez; Silvia Rodríguez-García; Felipe F Casanueva; Ana Fernández-Marmiesse; David Araújo-Vilar
Journal:  Endocrine       Date:  2016-07-30       Impact factor: 3.633

4.  LMNA missense mutations causing familial partial lipodystrophy do not lead to an accumulation of prelamin A.

Authors:  Yiping Tu; Sofía Sánchez-Iglesias; David Araújo-Vilar; Loren G Fong; Stephen G Young
Journal:  Nucleus       Date:  2016-09-02       Impact factor: 4.197

5.  The role of LMNA in adipose: a novel mouse model of lipodystrophy based on the Dunnigan-type familial partial lipodystrophy mutation.

Authors:  Kari M Wojtanik; Keith Edgemon; Srikant Viswanadha; Brigette Lindsey; Martin Haluzik; Weiping Chen; George Poy; Marc Reitman; Constantine Londos
Journal:  J Lipid Res       Date:  2009-02-05       Impact factor: 5.922

6.  Sex differences in human adipose tissues - the biology of pear shape.

Authors:  Kalypso Karastergiou; Steven R Smith; Andrew S Greenberg; Susan K Fried
Journal:  Biol Sex Differ       Date:  2012-05-31       Impact factor: 5.027

7.  Recombinant human leptin treatment in genetic lipodystrophic syndromes: the long-term Spanish experience.

Authors:  David Araujo-Vilar; Sofía Sánchez-Iglesias; Cristina Guillín-Amarelle; Ana Castro; Mary Lage; Marcos Pazos; José Manuel Rial; Javier Blasco; Encarna Guillén-Navarro; Rosario Domingo-Jiménez; María Ruiz del Campo; Blanca González-Méndez; Felipe F Casanueva
Journal:  Endocrine       Date:  2014-11-04       Impact factor: 3.633

Review 8.  Clinical Features and Management of Non-HIV-Related Lipodystrophy in Children: A Systematic Review.

Authors:  Nidhi Gupta; Noor Asi; Wigdan Farah; Jehad Almasri; Patricia Barrionuevo; Mouaz Alsawas; Zhen Wang; Morey W Haymond; Rebecca J Brown; M Hassan Murad
Journal:  J Clin Endocrinol Metab       Date:  2017-02-01       Impact factor: 5.958

9.  Partial lipodystrophy with severe insulin resistance and adult progeria Werner syndrome.

Authors:  Bruno Donadille; Pascal D'Anella; Martine Auclair; Nancy Uhrhammer; Marc Sorel; Romulus Grigorescu; Sophie Ouzounian; Gilles Cambonie; Pierre Boulot; Pascal Laforêt; Bruno Carbonne; Sophie Christin-Maitre; Yves-Jean Bignon; Corinne Vigouroux
Journal:  Orphanet J Rare Dis       Date:  2013-07-12       Impact factor: 4.123

Review 10.  Lipodystrophic laminopathies: Diagnostic clues.

Authors:  Cristina Guillín-Amarelle; Antía Fernández-Pombo; Sofía Sánchez-Iglesias; David Araújo-Vilar
Journal:  Nucleus       Date:  2018-01-01       Impact factor: 4.197

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.